← Insider buys

Ron Bentsur has bought stock on 12 days since Feb 2022

Chair and CEO at Nuvectis Pharma, Inc., and 1 other company

SEC CIK 0001251213 · Filings on SEC.gov ↗

$2.3MBought
$1.4MSold
Jul 1Last buy

Ron Bentsur's record

3 months after each buy, from the first price a copier could get.

+50.6%Average
+54.9 ptsVs S&P 500
8 of 12Higher

12 buys since 2022 with 3 months of prices.

Companies

Every filing

27 filings since Jul 2020, newest first

Filings come from SEC EDGAR. Not investment advice.